Danaher Q3 Earnings Beat Estimates, Life Sciences Sales Up Y/Y

Key Takeaways Danaher's Q3 adjusted EPS rose 10.5% year over year to $1.89, topping consensus estimates.Net sales grew 4.5% to $6.05 billion, with all segments contributing to year-over-year gains.Operating profit jumped 20.5%, expanding margins to 19.1% from 16.5% in the prior year.Danaher Corporation’s (DHR) third-quarter 2025 adjusted earnings of $1.89 per share beat the Zacks Consensus Estimate of $1.71. The bottom line increased 10.5% year over year.Danaher reported net sales of $6.05 billion, which be ...